Physician profile
Gregory A Barme
NPI 1295700235
$9,645.87
in general payments reported to CMS, 2019-2025
44 companies · $1,980 in 2025
The $1,980 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,364 · 2020: $1,868 · 2021: $1,089 · 2022: $1,200 · 2023: $245 · 2024: $900 · 2025: $1,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,034 · Education: $90.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.28 |
| Education | $90.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micro-Tech Endoscopy USA, INC. | $2,600.00 | 2019-2021 | |
| Astellas Pharma US INC | $1,129.19 | 2019-2025 | Xtandi, Myrbetriq |
| Neotract INC. | $833.36 | 2019-2020 | |
| Janssen Biotech, INC. | $753.44 | 2019-2025 | Erleada |
| Abbvie INC. | $573.86 | 2019-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $468.97 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $214.10 | 2019-2025 | |
| Amgen INC. | $205.69 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $205.40 | 2024-2025 | Trelstar, Tlando |
| Endo Pharmaceuticals INC. | $204.54 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $196.16 | 2019-2024 | Provenge |
| Ferring Pharmaceuticals INC. | $184.88 | 2025 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $162.90 | 2019-2025 | |
| Accord Healthcare, INC. | $160.26 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.48 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Barme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.